CAS: 2050478-92-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Cetrelimab REF: TM-T76945CAS: 2050478-92-5 | - - - | To inquire | Tue 03 Dec 24 |
 | Cetrelimab REF: 3D-CLA1518CAS: 2050478-92-5 | - - - | To inquire | Wed 11 Dec 24 |
Cetrelimab
CAS:2050478-92-5
Cetrelimab (JNJ 63723283; JNJ 3283), a humanized IgG4κ mAb, targets PD-1, blocks its PD-L1/L2 interaction, …
Color and Shape:
Liquid
Ref: TM-T76945
| 5mg | To inquire |
Estimated delivery in United States, on Tuesday 3 Dec 2024
Cetrelimab
CAS:2050478-92-5
An anti-human IgG4 kappa, anti-programmed cell death protein-1 (PD-1) antibody.
Ref: 3D-CLA1518
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
